Letrozole increases ovarian growth and CYP17A1 gene expression

Friday, March 1, 2013

Letrozole increases ovarian size and androgen production and upregulates Cyp17a1 messenger RNA expression in the rat ovary.

Read More

Aromatase Inhibitors for the Treatment of Endometriosis

Thursday, November 29, 2012

A review is presented of the role of aromatase in the pathogenesis of endometriosis, discuss the pharmacology of aromatase inhibitors, and examine clinical applications of aromatase inhibitors for endometriosis treatment.

Read More

Ovarian stimulation and fertility preservation using aromatase inhibitors in women with breast cancer

Thursday, November 29, 2012

Studies suggest that in the short term, an aromatase inhibitor plus gonadotropin protocol is effective for safely inducing controlled ovarian hyperstimulation in women with breast cancer for fertility preservation.

Read More

Does Higher Starting Dose of FSH Stimulation with Letrozole Improve Fertility Preservation Outcomes in Women with Breast Cancer

Thursday, September 27, 2012

Higher FSH start dose does not improve cycle outcomes in women with breast cancer undergoing fertility preservation with letrozole for embryo cryopreservation.

Read More

Effect of letrozole on estradiol production and P450 aromatase mRNA expression of cultured luteinized granulosa cells from women with and without endometriosis

Thursday, June 7, 2012

Lower estradiol production and P450 aromatase messenger RNA expression of cultured granulosa cells were found in women with endometriosis, but letrozole in the conditioned media further reduced these parameters.

Read More

Changes in the hormonal profile and seminal parameters with the use of aromatase inhibitors in the management of infertile men with low testosterone to estradiol ratios

Wednesday, June 6, 2012

Therapy with 2.5 mg letrozole or 1 mg anastrazole daily, in cases of infertile men with low T/E2 ratios, leads to a significant increase of T/E2 ratio, ejaculate volume, sperm motility, and total motile sperm count.

Read More

What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis of 988 cycles

Friday, May 4, 2012
ruler

The optimal size of the leading follicle in cycles with clomiphene citrate and letrozole is in the range of 23–28 mm and is closely related to the endometrial thickness.

Read More

Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B

Friday, May 4, 2012

This report describes the peripheral levels of inhibin B and antimullerian hormone in boys during peripuberty and in patients with congenital hypogonadotropic hypogonadism.

Read More